-
ImmunoPrecise Launches TATX-112 Antibody Program For Cancer, Alzheimer's Disease
Thursday, April 8, 2021 - 11:22am | 314Read More...ImmunoPrecise Antibodies Ltd's (NASDAQ: IPA) subsidiary Talem Therapeutics LLC has advanced developing a candidate referred to as TATX-112, against an undisclosed target, into formal lead candidate characterization. The target is a protein receptor that is...
-
Aikido Secures Sublicense For Psilocybin Treatment of Neuro-Inflamed Tissue in Cancer Patients
Wednesday, April 7, 2021 - 10:39am | 220Read More...Aikido Pharma Inc (NASDAQ: AIKI) has been granted an exclusive sublicense to technology related to the use of the central nervous system (CNS) homing peptides to treat neuroinflammatory disease in cancer patients. The homing peptides covered by the sublicense can facilitate the...
-
PsiOxus Therapeutics-Bristol Myers Expand Immuno-Oncology Collaboration
Wednesday, April 7, 2021 - 7:04am | 250Read More...PsiOxus Therapeutics Ltd has updated the agreement to advance its clinical collaboration with Bristol-Myers Squibb Co (NYSE: BMY) to evaluate PsiOxus' tumor re-engineering platform, in combination with BMY's Opdivo (nivolumab) to treat a range of tumor types....
-
Turning Point's RET Inhibitor Candidate Shows Tolerable Safety Profile, Early Signals Of Activity In Solid Tumor Settings
Tuesday, April 6, 2021 - 6:35am | 286Read More...Turning Point Therapeutics Inc (NASDAQ: TPTX) has reported initial data from the ongoing Phase 1/2 SWORD-1 study evaluating its RET inhibitor drug candidate, TPX-0046, in adult subjects with advanced or metastatic solid tumors harboring RET mutations or alterations....
-
Karyopharm Stock Is Trading Higher After China's NMPA Signs Off Early-Stage ATG-019 Study In Cancer Settings
Tuesday, April 6, 2021 - 6:19am | 217Read More...The National Medical Products Administration (NMPA) has approved Antengene Corporation Limited's Investigational New Drug Application for a Phase 1 trial of ATG-019 in China. The trial will evaluate the safety and tolerability of ATG-019 (monotherapy or combined with niacin ER)...
-
ICAD Focuses On Areas Of High Unmet Need In Cancer Detection, BTIG Says
Tuesday, March 23, 2021 - 2:39pm | 284Read More...ICAD Inc (NASDAQ: ICAD) is poised to benefit in the long term from its AI-driven cancer detection tools and electronic brachytherapy product, according to BTIG. The iCAD Analyst: Marie Thibault initiated coverage of iCAD with a Buy rating and a price target of $25. The iCAD Thesis: The company...
-
These 24 Psychedelic Patents Are Paving The Way For Medicine 2.0
Monday, March 22, 2021 - 4:06pm | 3275Read More...This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission. Mounting clinical research is demonstrating that psychedelic therapies are a game-changer when it comes to mental health treatment. And recent ...
-
Leap Therapeutics Stock Is Trading Higher After Encouraging DKN-01 Data At Gynecologic Oncology Meet
Monday, March 22, 2021 - 8:09am | 344Read More...Leap Therapeutics Inc (NASDAQ: LPTX) has announced the presentation of clinical data from its Phase 2 clinical trial of DKN-01 as a monotherapy and in combination with paclitaxel in patients with advanced gynecological malignancies. Leap presented the data at the Society of...
-
Immatics Stock Trading Higher As Cell Therapy Program Shows Anti-Tumor Activities In Pretreated Cancer Patients
Wednesday, March 17, 2021 - 11:40am | 230Read More...Immatics NV (NASDAQ: IMTX) has announced a clinical data update from the dose-escalation cohorts of the ongoing Phase 1 trial evaluating its ACTengine product candidates IMA201, IMA202, and IMA203. Data showed that first anti-tumor activity with 9 out of 10 evaluable patients showing...
-
3 Cancer Diagnostic Stocks To Watch Following Roche's GenMark Buy
Tuesday, March 16, 2021 - 11:41am | 927Read More...Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc (NASDAQ: GNMK) in a $1.8 billion deal on Monday, the same day Veracyte Inc (NASDAQ: VCYT) announced it completed the acquisition of Decipher Biosciences, Inc. What Happened: With the cancer...
-
AVEO Pharmaceuticals, CANbridge AV-203 Licensing Deal Axed, AVEO Regains Ex-North American Rights
Monday, March 15, 2021 - 10:41am | 313Read More...AVEO Pharmaceuticals Inc’s (NASDAQ: AVEO) brief positive news of getting FDA approval for Tivozanib in relapsed kidney cancer this month was upset after its partner CANbridge Life Sciences voluntarily terminated the collaboration agreement. The company said it would...
-
Exclusive: Greenwich LifeSciences CEO Calls Stock's Meteoric Rise 'Very Emotional'
Thursday, March 11, 2021 - 4:36pm | 646Read More...Greenwich LifeSciences, Inc. (NASDAQ: GLSI) is a biopharmaceutical company that is developing GP2, an immunotherapy to prevent breast cancer recurrences in certain patients. The stock skyrocketed nearly 3,000% in a single day in December after a Phase 2b trial suggested the therapy...
-
CASI Pharmaceuticals To Develop CB-5339 In Cancer Indications In China
Monday, March 8, 2021 - 11:17am | 232Read More...Cleave Therapeutics Inc has out-licensed CB-5339 to CASI Pharmaceuticals Inc (NASDAQ: CASI) in mainland China, Taiwan, Hong Kong, and Macau. Cleave and CASI will develop CB-5339 in both hematological malignancies and solid tumors under the terms of the agreement, with...
-
Compugen's COM701 Shows Ongoing Durable Signals In Early-Stage Solid Tumor Studies
Thursday, February 25, 2021 - 9:21am | 306Read More...Compugen Ltd (NASDAQ: CGEN) reports updated data from its Phase 1 dose-escalation and expansion study of COM701 as a monotherapy and a dose-escalation combination study with Bristol-Myers Squibb Co's (NYSE: BMY) Opdivo (nivolumab). COM701 is an antibody targeting...
-
Twist Bioscience Launches Methylation Detection Systems
Wednesday, February 24, 2021 - 12:06pm | 252Read More...Twist Bioscience Corp (NASDAQ: TWST) has launched its NGS Methylation Detection System, end-to-end sample preparation, and target enrichment solution for identifying methylated regions in the human genome. DNA methylation plays a key role in many biological processes, including...
